The Chinese Cancer Fix
A quiet revolution is underway in Indian oncology. Chinese-origin cancer drugs, brought to India through a growing number of pharma partnerships, are dramatically cutting the cost of immunotherapy — making treatment accessible to patients who previously had no options. Doctors are prescribing them, patients are…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →
Similar episodes from other shows
More like The Morning Brief →
Where are Indian patients getting their cancer drugs from?
How can India’s pharma companies survive under Trump’s uncertainty?
Indian pharma wants to conquer cancer
Express Investigation: How a life saving cancer drug is counterfeited
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.